CeriBell Inc
CBLL21.420USD
+0.130+0.61%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
793.58MMarket Cap
LossP/E TTM
More Details of CeriBell Inc Company
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
CeriBell Inc Info
Ticker SymbolCBLL
Company nameCeribell Inc
IPO dateOct 11, 2024
CEOChao (Xingjuan)
Number of employees281
Security typeOrdinary Share
Fiscal year-endOct 11
Address360 N. Pastoria Avenue
CitySUNNYVALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94085
Phone18004360826
Websitehttps://ceribell.com/
Ticker SymbolCBLL
IPO dateOct 11, 2024
CEOChao (Xingjuan)
Company Executives of CeriBell Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
--
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Ms. Erica J. Rogers
Ms. Erica J. Rogers
Director
Director
--
--
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
--
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Other
58.67%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Other
58.67%
Shareholder Types
Shareholders
Proportion
Investment Advisor
39.88%
Investment Advisor/Hedge Fund
17.92%
Private Equity
10.70%
Individual Investor
10.53%
Venture Capital
6.71%
Hedge Fund
4.45%
Research Firm
1.48%
Pension Fund
0.36%
Bank and Trust
0.22%
Other
7.75%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
202
30.92M
84.91%
-28.12K
2025Q3
202
30.95M
85.03%
-25.06K
2025Q2
178
30.95M
75.12%
+1.98M
2025Q1
151
30.66M
70.71%
+5.27M
2024Q4
110
29.39M
58.97%
+8.25M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.69M
12.79%
-62.59K
-1.32%
Jun 30, 2025
TPG Capital, L.P.
3.97M
10.82%
--
--
Jun 30, 2025
Longitude Capital Management Co., LLC
2.48M
6.75%
+2.48M
--
Oct 16, 2024
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.46%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.02%
--
--
Jun 30, 2025
Parvizi (Josef)
2.09M
5.7%
+6.62K
+0.32%
Apr 11, 2025
Ally Bridge Group (HK) Limited
2.44M
6.66%
+265.06K
+12.18%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.37M
3.74%
+587.42K
+75.05%
Jun 30, 2025
The Vanguard Group, Inc.
1.33M
3.61%
+631.24K
+90.98%
Jun 30, 2025
Chao (Xingjuan)
1.10M
3%
-2.89K
-0.26%
Aug 25, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
0.57%
Hypatia Women CEO ETF
0.5%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
View more
iShares Neuroscience and Healthcare ETF
Proportion0.57%
Hypatia Women CEO ETF
Proportion0.5%
Fidelity Fundamental Small-Mid Cap ETF
Proportion0.1%
iShares Micro-Cap ETF
Proportion0.06%
ProShares Hedge Replication ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of CeriBell Inc?
The top five shareholders of CeriBell Inc are:
Fidelity Management & Research Company LLC holds 4.69M shares, accounting for 12.79% of the total shares.
TPG Capital, L.P. holds 3.97M shares, accounting for 10.82% of the total shares.
Longitude Capital Management Co., LLC holds 2.48M shares, accounting for 6.75% of the total shares.
Global Value Investment Portfolio Management Pte. Ltd. holds 2.37M shares, accounting for 6.46% of the total shares.
Red Tree Management, LLC holds 2.21M shares, accounting for 6.02% of the total shares.
Fidelity Management & Research Company LLC holds 4.69M shares, accounting for 12.79% of the total shares.
TPG Capital, L.P. holds 3.97M shares, accounting for 10.82% of the total shares.
Longitude Capital Management Co., LLC holds 2.48M shares, accounting for 6.75% of the total shares.
Global Value Investment Portfolio Management Pte. Ltd. holds 2.37M shares, accounting for 6.46% of the total shares.
Red Tree Management, LLC holds 2.21M shares, accounting for 6.02% of the total shares.
What are the top three shareholder types of CeriBell Inc?
The top three shareholder types of CeriBell Inc are:
Fidelity Management & Research Company LLC
TPG Capital, L.P.
Longitude Capital Management Co., LLC
Fidelity Management & Research Company LLC
TPG Capital, L.P.
Longitude Capital Management Co., LLC
How many institutions hold shares of CeriBell Inc (CBLL)?
As of 2025Q4, 202 institutions hold shares of CeriBell Inc, with a combined market value of approximately 30.92M, accounting for 84.91% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.12%.
What is the biggest source of revenue for CeriBell Inc?
In FY2025Q2, the EEG recorders and EEG headbands, point in time business generated the highest revenue for CeriBell Inc, amounting to 15.92M and accounting for 75.11% of total revenue.
